![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 35, 23561-23567, Dec, 1991
M Balazy
Radiolabeled cis-(+-)-5,6-epoxyeicosatrienoic acid (5(6)-EpETrE) was
incubated with a suspension of isolated human platelets in order to study
its metabolic fate. The epoxide slowly disappeared from the suspension and
was completely metabolized within 30 min. After extraction and analysis by
reverse-phase high performance liquid chromatography, seven metabolites
were found. Addition of either indomethacin (0.01 mM, cyclooxygenase
inhibitor) or BW755C (0.1 mM, cyclooxygenase/lipoxygenase inhibitor) to the
incubations blocked the formation of four and six metabolites,
respectively, 1,2-Epoxy-3,3,3- trichloropropane (inhibitor of microsomal
epoxide hydrolase) failed to inhibit the formation of
5,6-dihydroxyeicosatrienoic acid (5,6- DiHETrE), a hydrolysis product of
the precursor 5(6)-EpETrE. The metabolites were characterized by UV
spectroscopy, negative ion chemical ionization liquid chromatography/mass
spectrometry, gas chromatography/mass spectrometry and, in one instance,
coelution with synthetic standard. Three primary platelet metabolites were
structurally determined to be 5,6-epoxy-12-hydroxyeicosatrienoic acid,
5,6-epoxy-12-hydroxyheptadecadienoic acid, and a unique bicyclic
metabolite, 5-hydroxy-6,9-epoxy-thromboxane B1, which originated from
intramolecular hydrolysis of 5,6-epoxythromboxane-B1. This thromboxane
analog was partially separated into stereoisomers and coeluted with the
racemic synthetic standard in gas chromatography/mass spectrometry and
liquid chromatography/mass spectrometry. Three other metabolites were
characterized as 5,6,12-trihydroxyeicosatrienoic acid, 5,6,12-
trihydroxyheptadecadienoic acid, and 5,6-dihydroxythromboxane-B1, and
resulted from the hydrolysis of the corresponding epoxides rather than from
the metabolism of 5,6-DiHETrE. The latter was not metabolized by platelet
cyclooxygenase or lipoxygenase. The biosynthesis of two cyclooxygenase
metabolites indicated the formation of unstable 5,6- epoxythromboxane-A1 as
an intermediate precursor. Platelet aggregation was not induced by
5(6)-EpETrE, although responsiveness to arachidonic acid was reduced
following preincubation with the epoxide. The platelet metabolites of
5(6)-EpETrE might be useful in assessing its in vivo production in humans.
Metabolism of 5,6-epoxyeicosatrienoic acid by the human platelet. Formation of novel thromboxane analogs
Department of Pharmacology, New York Medical College, Valhalla 10595.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. Balazy, T. Iesaki, J. L. Park, H. Jiang, P. M. Kaminski, and M. S. Wolin Vicinal Nitrohydroxyeicosatrienoic Acids: Vasodilator Lipids Formed by Reaction of Nitrogen Dioxide with Arachidonic Acid J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 611 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Fleming Cytochrome P450 and Vascular Homeostasis Circ. Res., October 26, 2001; 89(9): 753 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boulos, H. Jiang, and M. Balazy Diffusion of Peroxynitrite into the Human Platelet Inhibits Cyclooxygenase via Nitration of Tyrosine Residues J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 222 - 229. [Abstract] [Full Text] |
||||
![]() |
H. Jiang, N. Kruger, D. R. Lahiri, D. Wang, J.-M. Vatele, and M. Balazy Nitrogen Dioxide Induces cis-trans-Isomerization of Arachidonic Acid within Cellular Phospholipids. DETECTION OF TRANS-ARACHIDONIC ACIDS IN VIVO J. Biol. Chem., June 4, 1999; 274(23): 16235 - 16241. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Graber, A. Alfonso, and D. L. Gill Recovery of Ca2+ Pools and Growth in Ca2+ Pool-depleted Cells Is Mediated by Specific Epoxyeicosatrienoic Acids Derived from Arachidonic Acid J. Biol. Chem., November 21, 1997; 272(47): 29546 - 29553. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. VanRollins, T. L. Kaduce, X. Fang, H. R. Knapp, and A. A. Spector Arachidonic Acid Diols Produced by Cytochrome P-450 Monooxygenases Are Incorporated into Phospholipids of Vascular Endothelial Cells J. Biol. Chem., June 14, 1996; 271(24): 14001 - 14009. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhu, E. B. Schieber, J. C. McGiff, and M. Balazy Identification of Arachidonate P-450 Metabolites in Human Platelet Phospholipids Hypertension, April 1, 1995; 25(4): 854 - 859. [Abstract] [Full Text] |
||||
![]() |
E. D. Thuresson, M. G. Malkowski, K. M. Lakkides, C. J. Rieke, A. M. Mulichak, S. L. Ginell, R. M. Garavito, and W. L. Smith Mutational and X-ray Crystallographic Analysis of the Interaction of Dihomo-gamma -linolenic Acid with Prostaglandin Endoperoxide H Synthases J. Biol. Chem., March 23, 2001; 276(13): 10358 - 10365. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Malkowski, E. D. Thuresson, K. M. Lakkides, C. J. Rieke, R. Micielli, W. L. Smith, and R. M. Garavito Structure of Eicosapentaenoic and Linoleic Acids in the Cyclooxygenase Site of Prostaglandin Endoperoxide H Synthase-1 J. Biol. Chem., September 28, 2001; 276(40): 37547 - 37555. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |